首页 > 最新文献

Surgical Case Reports最新文献

英文 中文
Primary ileal myeloid sarcoma presenting with bowel obstruction: a case report. 以肠梗阻为表现的原发性回肠髓样肉瘤:一份病例报告。
IF 0.7 Q4 SURGERY Pub Date : 2024-10-04 DOI: 10.1186/s40792-024-02030-5
Hitoshi Minagi, Nobuhiko Kanaya, Yoshitaka Kondo, Yoshihiko Kakiuchi, Shinji Kuroda, Ryohei Shoji, Hajime Kashima, Yuki Matsumi, Satoru Kikuchi, Kunitoshi Shigeyasu, Fuminori Teraishi, Shunsuke Kagawa, Toshiyoshi Fujiwara

Background: Myeloid sarcoma (MS) is an extramedullary tumor constituted by myeloid blasts or immature myeloid cells. It frequently occurs in conjunction with acute myeloid leukemia (AML); however, it can exceptionally manifest in patients without leukemia. Here, we present a rare case of primary MS originating in the small bowel without evidence of bone marrow involvement.

Case representation: A 33 year-old female with no relevant medical history was admitted to our hospital with recurrent abdominal pain. Computed tomography (CT) revealed bowel obstruction due to thickening of the ileum wall, which was suspected to be an ileal tumor. Initially, ectopic endometriosis was suspected because of abdominal pain associated with the menstrual cycle and changes observed on a follow-up CT scan. The lesion could not be detected by double-balloon endoscopy. Despite conservative treatment, the obstruction persisted, and laparoscopic partial ileal resection was performed, which revealed extensive involvement of the ileum and mesentery. Additionally, the mesentery of the resected ileum was extremely thickened. Histopathological and immunohistochemical examinations of the surgical specimen indicated ileal MS. Bone marrow aspiration after discharge was negative for cytological findings of leukemia, leading to a final diagnosis of primary ileal MS. Her postoperative course was uneventful, and she is currently undergoing systemic chemotherapy tailored to AML at another hospital.

Conclusions: Even though MS of the small bowel is rare and may not be considered preoperatively, similar surgical treatment to that of other small bowel malignancies can ensure proper postoperative diagnosis and appropriate chemotherapy. Given the potential need for chemotherapy, ensuring surgical safety that allows for its rapid initiation is critical.

背景:髓样肉瘤(MS)是由髓样胚块或未成熟髓样细胞构成的髓外肿瘤。它经常与急性髓系白血病(AML)同时发生,但也可在无白血病的患者中出现异常表现。在此,我们介绍一例罕见的原发性多发性骨髓瘤病例,该病起源于小肠,但无骨髓受累的证据:一名 33 岁女性,无相关病史,因反复腹痛入住我院。计算机断层扫描(CT)显示回肠壁增厚导致肠梗阻,怀疑为回肠肿瘤。最初怀疑是异位子宫内膜异位症,因为腹痛与月经周期有关,而且在随访的 CT 扫描中也观察到了变化。双气囊内镜检查未能发现病变。尽管进行了保守治疗,但梗阻仍然存在,于是进行了腹腔镜回肠部分切除术,结果发现回肠和肠系膜广泛受累。此外,切除的回肠系膜极度增厚。手术标本的组织病理学和免疫组化检查显示回肠多发性硬化。出院后进行的骨髓穿刺检查显示白血病细胞学结果为阴性,最终诊断为原发性回肠多发性硬化症。她的术后恢复顺利,目前正在另一家医院接受针对急性髓细胞白血病的全身化疗:结论:尽管小肠多发性硬化非常罕见,而且术前可能不会考虑,但与其他小肠恶性肿瘤相似的手术治疗可确保术后诊断正确并进行适当的化疗。考虑到化疗的潜在需求,确保手术安全以迅速启动化疗至关重要。
{"title":"Primary ileal myeloid sarcoma presenting with bowel obstruction: a case report.","authors":"Hitoshi Minagi, Nobuhiko Kanaya, Yoshitaka Kondo, Yoshihiko Kakiuchi, Shinji Kuroda, Ryohei Shoji, Hajime Kashima, Yuki Matsumi, Satoru Kikuchi, Kunitoshi Shigeyasu, Fuminori Teraishi, Shunsuke Kagawa, Toshiyoshi Fujiwara","doi":"10.1186/s40792-024-02030-5","DOIUrl":"10.1186/s40792-024-02030-5","url":null,"abstract":"<p><strong>Background: </strong>Myeloid sarcoma (MS) is an extramedullary tumor constituted by myeloid blasts or immature myeloid cells. It frequently occurs in conjunction with acute myeloid leukemia (AML); however, it can exceptionally manifest in patients without leukemia. Here, we present a rare case of primary MS originating in the small bowel without evidence of bone marrow involvement.</p><p><strong>Case representation: </strong>A 33 year-old female with no relevant medical history was admitted to our hospital with recurrent abdominal pain. Computed tomography (CT) revealed bowel obstruction due to thickening of the ileum wall, which was suspected to be an ileal tumor. Initially, ectopic endometriosis was suspected because of abdominal pain associated with the menstrual cycle and changes observed on a follow-up CT scan. The lesion could not be detected by double-balloon endoscopy. Despite conservative treatment, the obstruction persisted, and laparoscopic partial ileal resection was performed, which revealed extensive involvement of the ileum and mesentery. Additionally, the mesentery of the resected ileum was extremely thickened. Histopathological and immunohistochemical examinations of the surgical specimen indicated ileal MS. Bone marrow aspiration after discharge was negative for cytological findings of leukemia, leading to a final diagnosis of primary ileal MS. Her postoperative course was uneventful, and she is currently undergoing systemic chemotherapy tailored to AML at another hospital.</p><p><strong>Conclusions: </strong>Even though MS of the small bowel is rare and may not be considered preoperatively, similar surgical treatment to that of other small bowel malignancies can ensure proper postoperative diagnosis and appropriate chemotherapy. Given the potential need for chemotherapy, ensuring surgical safety that allows for its rapid initiation is critical.</p>","PeriodicalId":22096,"journal":{"name":"Surgical Case Reports","volume":"10 1","pages":"229"},"PeriodicalIF":0.7,"publicationDate":"2024-10-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11452573/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142372918","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Intraoperative indocyanine green fluorescence for precise resection of nonocclusive mesenteric ischemia: a case report and diagnostic considerations based on pathology findings. 术中吲哚菁绿荧光精确切除非闭塞性肠系膜缺血:病例报告和基于病理结果的诊断考虑。
IF 0.7 Q4 SURGERY Pub Date : 2024-10-04 DOI: 10.1186/s40792-024-02024-3
Akihito Mizukami, Shinji Furuya, Koichi Takiguchi, Kensuke Shiraishi, Yuki Nakata, Hidenori Akaike, Yoshihiko Kawaguchi, Hidetake Amemiya, Hiromichi Kawaida, Daisuke Ichikawa

Background: Nonocclusive mesenteric ischemia (NOMI) is characterized by intestinal ischemia caused by spasms in the peripheral intestinal vessels without organic obstruction in the main mesenteric vessels. NOMI can be fatal in case of delayed diagnosis and treatment. Although the use of indocyanine green (ICG) fluorescence in assessing intestinal viability during NOMI surgery is well recognized, there is a paucity of reported cases using this technique. Herein, we present a case of NOMI that was successfully managed through accurate diagnosis and resection of the ischemic intestines guided by ICG fluorescence.

Case presentation: An 81-year-old man presented with abdominal pain. Contrast-enhanced computed tomography revealed intrahepatic portal vein gas, superior mesenteric vein gas, and terminal ileal edema. Considering these findings, the patient was diagnosed with NOMI and emergency surgery was performed. Intestinal edema was observed 30 cm upstream of the terminal ileum without serosal discoloration. ICG fluorescence revealed areas of normal perfusion as well as mild and moderate hypoperfusion. The small bowel, including the hypoperfusion area, was resected. As no clinical signs of residual bowel ischemia were observed during the postoperative course, a second-look operation was deemed unnecessary. Intraoperative ICG fluorescence and histopathological findings indicated mucosal edema in the mildly hypoperfused area and mucosal necrosis in the moderately hypoperfused area.

Conclusions: This case highlights the use of intraoperative ICG fluorescence in the disease. ICG fluorescence is invaluable in assessing the extent of bowel ischemia and guiding precise resection. Thus, future efforts should focus on identifying accumulation of cases and quantification of ICG fluorescence intensity to further improve diagnostic performance.

背景:非闭塞性肠系膜缺血(NOMI)的特点是肠外周血管痉挛导致肠缺血,而肠系膜主血管无器质性阻塞。如果延误诊断和治疗,NOMI 可导致死亡。尽管吲哚菁绿(ICG)荧光技术在 NOMI 手术中用于评估肠道存活率已得到广泛认可,但使用该技术的病例却鲜有报道。在此,我们介绍一例通过 ICG 荧光准确诊断并切除缺血肠道而成功治愈的 NOMI 病例:病例介绍:一名 81 岁的男性因腹痛前来就诊。对比增强计算机断层扫描显示肝内门静脉积气、肠系膜上静脉积气和回肠末端水肿。考虑到这些发现,患者被诊断为 NOMI,并接受了急诊手术。在回肠末端上游30厘米处观察到肠道水肿,但无血清变色。ICG 荧光显示有正常灌注区域以及轻度和中度灌注不足区域。包括灌注不足区域在内的小肠被切除。由于术后没有观察到残余肠缺血的临床症状,因此认为没有必要进行二次手术。术中 ICG 荧光和组织病理学检查结果显示,轻度低灌注区粘膜水肿,中度低灌注区粘膜坏死:本病例强调了术中 ICG 荧光在疾病中的应用。ICG 荧光在评估肠缺血程度和指导精确切除方面具有重要价值。因此,今后的工作重点应放在识别病例的累积和 ICG 荧光强度的量化上,以进一步提高诊断性能。
{"title":"Intraoperative indocyanine green fluorescence for precise resection of nonocclusive mesenteric ischemia: a case report and diagnostic considerations based on pathology findings.","authors":"Akihito Mizukami, Shinji Furuya, Koichi Takiguchi, Kensuke Shiraishi, Yuki Nakata, Hidenori Akaike, Yoshihiko Kawaguchi, Hidetake Amemiya, Hiromichi Kawaida, Daisuke Ichikawa","doi":"10.1186/s40792-024-02024-3","DOIUrl":"10.1186/s40792-024-02024-3","url":null,"abstract":"<p><strong>Background: </strong>Nonocclusive mesenteric ischemia (NOMI) is characterized by intestinal ischemia caused by spasms in the peripheral intestinal vessels without organic obstruction in the main mesenteric vessels. NOMI can be fatal in case of delayed diagnosis and treatment. Although the use of indocyanine green (ICG) fluorescence in assessing intestinal viability during NOMI surgery is well recognized, there is a paucity of reported cases using this technique. Herein, we present a case of NOMI that was successfully managed through accurate diagnosis and resection of the ischemic intestines guided by ICG fluorescence.</p><p><strong>Case presentation: </strong>An 81-year-old man presented with abdominal pain. Contrast-enhanced computed tomography revealed intrahepatic portal vein gas, superior mesenteric vein gas, and terminal ileal edema. Considering these findings, the patient was diagnosed with NOMI and emergency surgery was performed. Intestinal edema was observed 30 cm upstream of the terminal ileum without serosal discoloration. ICG fluorescence revealed areas of normal perfusion as well as mild and moderate hypoperfusion. The small bowel, including the hypoperfusion area, was resected. As no clinical signs of residual bowel ischemia were observed during the postoperative course, a second-look operation was deemed unnecessary. Intraoperative ICG fluorescence and histopathological findings indicated mucosal edema in the mildly hypoperfused area and mucosal necrosis in the moderately hypoperfused area.</p><p><strong>Conclusions: </strong>This case highlights the use of intraoperative ICG fluorescence in the disease. ICG fluorescence is invaluable in assessing the extent of bowel ischemia and guiding precise resection. Thus, future efforts should focus on identifying accumulation of cases and quantification of ICG fluorescence intensity to further improve diagnostic performance.</p>","PeriodicalId":22096,"journal":{"name":"Surgical Case Reports","volume":"10 1","pages":"230"},"PeriodicalIF":0.7,"publicationDate":"2024-10-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11452368/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142372916","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Massive enteric necrosis caused by histiocytic sarcoma embolism: a case report. 组织细胞肉瘤栓塞引起的大面积肠坏死:病例报告。
IF 0.7 Q4 SURGERY Pub Date : 2024-10-04 DOI: 10.1186/s40792-024-02031-4
Yoshitaka Imoto, Masato Yamadera, Hiroki Ohno, Koichi Okamoto, Yoshiki Kajiwara, Yoji Kishi, Hideyuki Shimazaki, Susumu Matsukuma, Hideki Ueno

Background: Histiocytic sarcoma (HS) is a rare disease characterized by the presence of neoplastic histiocytes. We herein report an unusual case of HS that caused massive tumor embolism-related transmural necrosis of the small intestine.

Case presentation: A 64-year-old man presented with multiple nodules in the lungs, bone, mediastinum, and subcutaneous tissues that were incidentally detected on preoperative computed tomography for early transverse colon cancer. Approximately two months later, the patient presented with signs of peritoneal irritation suggestive of small intestinal necrosis. Emergency surgery was performed and the necrotic small intestine was resected. Pathological examination revealed small bowel necrosis due to multifocal HS embolism. The postoperative course was uneventful. The patient was unsuccessfully treated with chemotherapy for HS and died 122 days postoperatively.

Conclusions: HS can cause massive enteric necrosis due to tumor embolism. Clinicians should be aware of this rare presentation of HS.

背景:组织细胞肉瘤(HS)是一种以肿瘤性组织细胞为特征的罕见疾病。我们在此报告了一例不同寻常的组织细胞肉瘤病例,该病例引起了与肿瘤栓塞相关的小肠大面积跨壁坏死:一名 64 岁的男子因早期横结肠癌术前计算机断层扫描偶然发现肺部、骨骼、纵隔和皮下组织有多个结节。大约两个月后,患者出现腹膜刺激症状,提示小肠坏死。患者接受了紧急手术,切除了坏死的小肠。病理检查显示,小肠坏死是由于多灶性 HS 栓塞所致。术后恢复顺利。患者接受 HS 化疗未果,术后 122 天死亡:结论:HS可因肿瘤栓塞导致大面积肠坏死。临床医生应注意这种罕见的 HS 表现。
{"title":"Massive enteric necrosis caused by histiocytic sarcoma embolism: a case report.","authors":"Yoshitaka Imoto, Masato Yamadera, Hiroki Ohno, Koichi Okamoto, Yoshiki Kajiwara, Yoji Kishi, Hideyuki Shimazaki, Susumu Matsukuma, Hideki Ueno","doi":"10.1186/s40792-024-02031-4","DOIUrl":"10.1186/s40792-024-02031-4","url":null,"abstract":"<p><strong>Background: </strong>Histiocytic sarcoma (HS) is a rare disease characterized by the presence of neoplastic histiocytes. We herein report an unusual case of HS that caused massive tumor embolism-related transmural necrosis of the small intestine.</p><p><strong>Case presentation: </strong>A 64-year-old man presented with multiple nodules in the lungs, bone, mediastinum, and subcutaneous tissues that were incidentally detected on preoperative computed tomography for early transverse colon cancer. Approximately two months later, the patient presented with signs of peritoneal irritation suggestive of small intestinal necrosis. Emergency surgery was performed and the necrotic small intestine was resected. Pathological examination revealed small bowel necrosis due to multifocal HS embolism. The postoperative course was uneventful. The patient was unsuccessfully treated with chemotherapy for HS and died 122 days postoperatively.</p><p><strong>Conclusions: </strong>HS can cause massive enteric necrosis due to tumor embolism. Clinicians should be aware of this rare presentation of HS.</p>","PeriodicalId":22096,"journal":{"name":"Surgical Case Reports","volume":"10 1","pages":"228"},"PeriodicalIF":0.7,"publicationDate":"2024-10-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11452572/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142372917","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Laparoscopic endoscopic cooperative surgery for gastric subepithelial lesion during laparoscopic sleeve gastrectomy for severe obesity. 腹腔镜袖状胃切除术治疗重度肥胖时的胃上皮下病变的腹腔镜内镜合作手术。
IF 0.7 Q4 SURGERY Pub Date : 2024-09-26 DOI: 10.1186/s40792-024-02027-0
Takumi Miwa, Yuji Ishibashi, Fumihiko Hatao, Kohei Shimoji, Kazuhiro Imamura, Yasuhiro Morita

Background: The frequency of pathologies detected incidentally before, during, and after a bariatric surgery, such as subepithelial lesion (SEL) of the stomach, is likely to rise as bariatric surgery becomes more common.

Case presentation: A 49-year-old female patient presented with severe obesity, for which laparoscopic sleeve gastrectomy (LSG) was planned. During a preoperative examination, endoscopy revealed a 10 mm SEL in the posterior wall of the upper body of the stomach. Excision of the SEL was performed simultaneously with the LSG. Endoscopy demonstrated that the SEL was situated on the remnant side of the stomach. Endoscopic resection using laparoscopic endoscopic cooperative surgery was performed for the SEL, and the thinned gastric wall was closed by hand-sewing. Thereafter, LSG was performed. Pathological analysis of the SEL led to a diagnosis of leiomyoma. The patient was discharged on postoperative day 6.

Conclusion: Surgeons should be prepared to manage incidentally detected pathologies before, during, and after bariatric surgery and to choose the surgical method most suitable to the individual patient.

背景:随着减肥手术越来越普遍,在减肥手术前、手术中和手术后偶然发现的病变(如胃上皮下病变(SEL))的频率可能会上升:一名 49 岁的女性患者患有严重肥胖症,计划进行腹腔镜袖带胃切除术(LSG)。在术前检查中,内镜检查发现胃上部后壁有一个 10 毫米的 SEL。切除 SEL 与 LSG 同时进行。内镜检查显示 SEL 位于胃的残余侧。使用腹腔镜内镜合作手术对 SEL 进行了内镜切除,并用手缝合了变薄的胃壁。之后,进行了 LSG。对 SEL 进行病理分析后,确诊为子宫肌瘤。患者于术后第 6 天出院:外科医生应做好准备,在减肥手术前、手术中和手术后处理偶然发现的病变,并选择最适合患者个体情况的手术方法。
{"title":"Laparoscopic endoscopic cooperative surgery for gastric subepithelial lesion during laparoscopic sleeve gastrectomy for severe obesity.","authors":"Takumi Miwa, Yuji Ishibashi, Fumihiko Hatao, Kohei Shimoji, Kazuhiro Imamura, Yasuhiro Morita","doi":"10.1186/s40792-024-02027-0","DOIUrl":"https://doi.org/10.1186/s40792-024-02027-0","url":null,"abstract":"<p><strong>Background: </strong>The frequency of pathologies detected incidentally before, during, and after a bariatric surgery, such as subepithelial lesion (SEL) of the stomach, is likely to rise as bariatric surgery becomes more common.</p><p><strong>Case presentation: </strong>A 49-year-old female patient presented with severe obesity, for which laparoscopic sleeve gastrectomy (LSG) was planned. During a preoperative examination, endoscopy revealed a 10 mm SEL in the posterior wall of the upper body of the stomach. Excision of the SEL was performed simultaneously with the LSG. Endoscopy demonstrated that the SEL was situated on the remnant side of the stomach. Endoscopic resection using laparoscopic endoscopic cooperative surgery was performed for the SEL, and the thinned gastric wall was closed by hand-sewing. Thereafter, LSG was performed. Pathological analysis of the SEL led to a diagnosis of leiomyoma. The patient was discharged on postoperative day 6.</p><p><strong>Conclusion: </strong>Surgeons should be prepared to manage incidentally detected pathologies before, during, and after bariatric surgery and to choose the surgical method most suitable to the individual patient.</p>","PeriodicalId":22096,"journal":{"name":"Surgical Case Reports","volume":"10 1","pages":"223"},"PeriodicalIF":0.7,"publicationDate":"2024-09-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11427647/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142354234","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Resected intramuscular hemangioma in the chest wall: a case report. 胸壁肌肉内血管瘤切除术:病例报告。
IF 0.7 Q4 SURGERY Pub Date : 2024-09-26 DOI: 10.1186/s40792-024-02023-4
Yoshiyuki Nakanishi, Takaki Akamine, Fumihiko Kinoshita, Mikihiro Kohno, Keigo Ozono, Takuya Hino, Taro Mori, Yoshinao Oda, Tomoyoshi Takenaka, Masafumi Nakamura

Background: Intramuscular hemangioma is an uncommon benign tumor found mainly in the limbs of adolescents and young adults. The local recurrence rate is high, ranging from 30 to 50%, necessitating wide local excision of intercostal intramuscular hemangiomas. However, preoperative diagnosis of intramuscular hemangiomas is challenging. Herein, we report a rare case of an intramuscular hemangioma arising from the chest wall.

Case presentation: A healthy 29-year-old asymptomatic man was referred to our hospital after an abnormal shadow was observed on his chest radiography. Computed tomography and magnetic resonance imaging revealed a 30-mm-sized mass in the right second intercostal space. Neoplastic lesions, such as schwannomas or solitary fibrous tumors, were included in the preoperative differential diagnosis. Tumor resection was performed using video-assisted thoracoscopic surgery. The tumor, which had a smooth surface covered with parietal pleura, was dissected from the external intercostal muscle and costal bone. Postoperative histopathological examination revealed proliferation of spindle-shaped endothelial cells arranged in a capillary vascular structure accompanied by entrapped smooth muscle fibers, adipose tissue, and muscle vessels. The final diagnosis was an intramuscular hemangioma with negative surgical margins. There was no evidence of recurrence during the 1-year postoperative follow-up period.

Conclusion: Intramuscular hemangiomas should be considered in the differential diagnosis of chest wall tumors, particularly in young people, owing to their potential for recurrence. Moreover, postoperative follow-up may be necessary for resected intramuscular intercostal hemangiomas.

背景:肌内血管瘤是一种不常见的良性肿瘤,主要发生在青少年和年轻人的四肢。局部复发率很高,从 30% 到 50% 不等,因此有必要对肋间肌内血管瘤进行广泛的局部切除。然而,肌间血管瘤的术前诊断具有挑战性。在此,我们报告了一例罕见的胸壁肌内血管瘤病例:一名 29 岁无症状的健康男性因胸片发现异常阴影而被转诊至我院。计算机断层扫描和磁共振成像显示,右侧第二肋间隙有一个 30 毫米大小的肿块。术前鉴别诊断包括肿瘤病变,如分裂瘤或单发纤维瘤。采用视频辅助胸腔镜手术进行了肿瘤切除。肿瘤表面光滑,覆盖顶胸膜,从肋间外肌和肋骨上切除。术后组织病理学检查显示,呈纺锤形的内皮细胞增生,排列成毛细血管结构,并伴有夹杂的平滑肌纤维、脂肪组织和肌肉血管。最终诊断为肌肉内血管瘤,手术切缘阴性。术后 1 年的随访期间没有发现复发迹象:结论:由于肌内血管瘤有复发的可能性,因此在胸壁肿瘤的鉴别诊断中应考虑肌内血管瘤,尤其是年轻人。此外,切除的肋间肌内血管瘤可能需要术后随访。
{"title":"Resected intramuscular hemangioma in the chest wall: a case report.","authors":"Yoshiyuki Nakanishi, Takaki Akamine, Fumihiko Kinoshita, Mikihiro Kohno, Keigo Ozono, Takuya Hino, Taro Mori, Yoshinao Oda, Tomoyoshi Takenaka, Masafumi Nakamura","doi":"10.1186/s40792-024-02023-4","DOIUrl":"https://doi.org/10.1186/s40792-024-02023-4","url":null,"abstract":"<p><strong>Background: </strong>Intramuscular hemangioma is an uncommon benign tumor found mainly in the limbs of adolescents and young adults. The local recurrence rate is high, ranging from 30 to 50%, necessitating wide local excision of intercostal intramuscular hemangiomas. However, preoperative diagnosis of intramuscular hemangiomas is challenging. Herein, we report a rare case of an intramuscular hemangioma arising from the chest wall.</p><p><strong>Case presentation: </strong>A healthy 29-year-old asymptomatic man was referred to our hospital after an abnormal shadow was observed on his chest radiography. Computed tomography and magnetic resonance imaging revealed a 30-mm-sized mass in the right second intercostal space. Neoplastic lesions, such as schwannomas or solitary fibrous tumors, were included in the preoperative differential diagnosis. Tumor resection was performed using video-assisted thoracoscopic surgery. The tumor, which had a smooth surface covered with parietal pleura, was dissected from the external intercostal muscle and costal bone. Postoperative histopathological examination revealed proliferation of spindle-shaped endothelial cells arranged in a capillary vascular structure accompanied by entrapped smooth muscle fibers, adipose tissue, and muscle vessels. The final diagnosis was an intramuscular hemangioma with negative surgical margins. There was no evidence of recurrence during the 1-year postoperative follow-up period.</p><p><strong>Conclusion: </strong>Intramuscular hemangiomas should be considered in the differential diagnosis of chest wall tumors, particularly in young people, owing to their potential for recurrence. Moreover, postoperative follow-up may be necessary for resected intramuscular intercostal hemangiomas.</p>","PeriodicalId":22096,"journal":{"name":"Surgical Case Reports","volume":"10 1","pages":"225"},"PeriodicalIF":0.7,"publicationDate":"2024-09-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11427623/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142354236","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A case of isolated malrotation without midgut volvulus diagnosed prenatally and treated by laparoscopic surgery. 一例产前确诊的孤立性肠道旋转不良,但无中肠翻卷,经腹腔镜手术治疗。
IF 0.7 Q4 SURGERY Pub Date : 2024-09-26 DOI: 10.1186/s40792-024-02029-y
Kosuke Endo, Hiroaki Fukuzawa, Yumi Mizoue, Atsushi Higashio, Mari Sonoda, Tamaki Iwade, Masahito Sato

Background: Malrotation is a congenital condition that predisposes individuals to midgut volvulus, which can result in significant bowel resection. While most cases of malrotation are diagnosed by the age of 1 year, typically presenting with symptoms related to volvulus or bowel obstruction, some cases remain asymptomatic. In children with visceral malposition, gastroschisis, omphalocele, or diaphragmatic hernia, malrotation may be suspected before symptoms manifest. However, isolated malrotation without midgut volvulus diagnosed prenatally is rare. We herein present a case of isolated malrotation without midgut volvulus that was prenatally diagnosed and successfully treated with laparoscopic surgery.

Case presentation: A 30-year-old woman (gravida 3, para 1) underwent routine obstetric ultrasound, which revealed increased blood flow in the lower uterine segment and abnormal placental attachment. To rule out placenta percreta, magnetic resonance imaging was performed at 34 weeks of gestation. Incidentally, abnormal fetal intestinal arrangement was noted, with the colon localized in the left hemi-abdomen and the small intestine distributed in the right hemi-abdomen, raising suspicion of malrotation. Postnatal contrast studies confirmed the diagnosis of malrotation without midgut volvulus. Given the risk of midgut volvulus, a laparoscopic Ladd's procedure was performed on day 6 of life. The postoperative course was uneventful, and the patient was still symptom-free 1 year postoperatively.

Conclusions: This case illustrates that malrotation can be prenatally diagnosed using fetal magnetic resonance imaging. Considering the risk of midgut volvulus, prophylactic Ladd's procedure should be performed in neonatal period. In cases where malrotation is not complicated by midgut volvulus, a laparoscopic Ladd procedure can be safely performed in neonates.

背景:肠旋转不良是一种先天性疾病,易导致中肠翻卷,从而导致大肠切除。虽然大多数肠旋转不良病例在 1 岁前就能确诊,通常会出现与肠旋转或肠梗阻相关的症状,但有些病例仍无症状。对于内脏位置不正、胃裂、脐疝或膈疝的患儿,在出现症状之前就可能怀疑有旋转不良。然而,产前确诊的孤立性肠管旋转不良而无中肠翻卷的病例并不多见。我们在此介绍一例产前诊断为孤立性肠管旋转不良但无中肠翻卷的病例,并通过腹腔镜手术成功治疗了该病:病例介绍:一名 30 岁的妇女(孕 3,1 段)接受了常规产科超声波检查,结果显示子宫下段血流增加,胎盘附着异常。为排除胎盘早剥的可能,在妊娠 34 周时进行了磁共振成像检查。偶然发现胎儿肠道排列异常,结肠位于左半腹,小肠分布在右半腹,因此怀疑是肠旋转不良。出生后的造影检查证实了肠旋转不良的诊断,但没有中肠翻卷。考虑到中肠翻卷的风险,在婴儿出生后第 6 天为其实施了腹腔镜拉德氏手术。术后过程顺利,患者术后一年仍无症状:本病例说明,胎儿磁共振成像可以在产前诊断出肠管旋转不良。考虑到中肠旋转的风险,应在新生儿期进行预防性拉德氏手术。如果旋转不良没有并发中肠翻卷,则可以在新生儿中安全地进行腹腔镜拉德氏手术。
{"title":"A case of isolated malrotation without midgut volvulus diagnosed prenatally and treated by laparoscopic surgery.","authors":"Kosuke Endo, Hiroaki Fukuzawa, Yumi Mizoue, Atsushi Higashio, Mari Sonoda, Tamaki Iwade, Masahito Sato","doi":"10.1186/s40792-024-02029-y","DOIUrl":"https://doi.org/10.1186/s40792-024-02029-y","url":null,"abstract":"<p><strong>Background: </strong>Malrotation is a congenital condition that predisposes individuals to midgut volvulus, which can result in significant bowel resection. While most cases of malrotation are diagnosed by the age of 1 year, typically presenting with symptoms related to volvulus or bowel obstruction, some cases remain asymptomatic. In children with visceral malposition, gastroschisis, omphalocele, or diaphragmatic hernia, malrotation may be suspected before symptoms manifest. However, isolated malrotation without midgut volvulus diagnosed prenatally is rare. We herein present a case of isolated malrotation without midgut volvulus that was prenatally diagnosed and successfully treated with laparoscopic surgery.</p><p><strong>Case presentation: </strong>A 30-year-old woman (gravida 3, para 1) underwent routine obstetric ultrasound, which revealed increased blood flow in the lower uterine segment and abnormal placental attachment. To rule out placenta percreta, magnetic resonance imaging was performed at 34 weeks of gestation. Incidentally, abnormal fetal intestinal arrangement was noted, with the colon localized in the left hemi-abdomen and the small intestine distributed in the right hemi-abdomen, raising suspicion of malrotation. Postnatal contrast studies confirmed the diagnosis of malrotation without midgut volvulus. Given the risk of midgut volvulus, a laparoscopic Ladd's procedure was performed on day 6 of life. The postoperative course was uneventful, and the patient was still symptom-free 1 year postoperatively.</p><p><strong>Conclusions: </strong>This case illustrates that malrotation can be prenatally diagnosed using fetal magnetic resonance imaging. Considering the risk of midgut volvulus, prophylactic Ladd's procedure should be performed in neonatal period. In cases where malrotation is not complicated by midgut volvulus, a laparoscopic Ladd procedure can be safely performed in neonates.</p>","PeriodicalId":22096,"journal":{"name":"Surgical Case Reports","volume":"10 1","pages":"226"},"PeriodicalIF":0.7,"publicationDate":"2024-09-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11427646/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142354232","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Rectum necrosis in a patient with severe COVID19 infection after CAR-T therapy: a case report. CAR-T疗法后一名COVID19严重感染患者的直肠坏死:病例报告。
IF 0.7 Q4 SURGERY Pub Date : 2024-09-26 DOI: 10.1186/s40792-024-02026-1
Kiyoshi Saeki, Hidenobu Nakagama, Yuichi Tanaka, Yoshitaka Goto, Kazuhisa Kaneshiro, Hiroshi Kono, Kosuke Yanai, Hirofumi Yamamoto, Reiko Yoneda, Takashi Shimakawa, Takashi Ueki

Background: Coronavirus disease 2019 (COVID19) can cause gastrointestinal complications as well as respiratory tract disease. Coagulation abnormalities and thrombosis frequently occur in COVID19, especially in cases with severe clinical outcome. The relationship between gastrointestinal perforation and coagulopathy due to COVID19 remains unclear.

Case presentation: A 49-year-old female received Chimeric antigen receptor T (CAR-T) therapy for an early recurrence of diffuse large B-cell lymphoma (DLBCL) that was refractory to chemotherapy. She was diagnosed with cytokine release syndrome (CRS) because of a fever and oxygen desaturation, and administered tocilizumab. Forty days after completing CAR-T therapy, she was infected with COVID19 and transferred to our hospital. Her general condition worsened and she developed COVID19 pneumonia, and then steroid pulse therapy was started. While her respiratory condition improved, she experienced pain in the anal region and computed tomography (CT) revealed a rectal perforation. An emergency surgery was undertaken, and the lower rectum wall was found to be completely necrotic. Removal of the necrotic part of the rectum tissue, and drainage and lavage of necrotic tissue in the pelvic cavity were performed. The remaining rectum was resected with partial sigmoidectomy, but we could not make the anal stump closed. In addition, an end colostomy in the sigmoid colon was performed. Histopathological findings showed thromboses in the rectal mesentery veins. After the first surgery, the pelvic abscess cavity persisted and her high-grade fever continued. Reoperation was laparoscopically performed, and she underwent a resection of anal canal with residual necrotic rectal and mesorectal tissue, and a drainage of the pelvic abscess. After the reoperation, her general condition improved and CT showed that the abscess cavity had significantly improved.

Conclusions: Gastrointestinal perforation, especially rectal necrosis due to coagulopathy caused by severe COVID19 infection, is a rare but life-threatening complication. Physicians should have a high degree of clinical suspicion for timely diagnosis and management, and surgical intervention is necessary in cases of rectal necrosis.

背景:冠状病毒病 2019(COVID19)可引起胃肠道并发症和呼吸道疾病。COVID19 经常出现凝血异常和血栓形成,尤其是在临床后果严重的病例中。COVID19导致的胃肠道穿孔与凝血功能障碍之间的关系尚不清楚:一名 49 岁女性因化疗难治的弥漫大 B 细胞淋巴瘤(DLBCL)早期复发而接受嵌合抗原受体 T(CAR-T)治疗。由于发烧和血氧饱和度降低,她被诊断为细胞因子释放综合征(CRS),并接受了托珠单抗治疗。在完成CAR-T治疗40天后,她感染了COVID19,并转入我院。她的全身状况恶化,出现了 COVID19 肺炎,随后开始接受类固醇脉冲治疗。她的呼吸状况有所改善,但肛门部位出现疼痛,计算机断层扫描(CT)显示直肠穿孔。患者接受了紧急手术,发现直肠下壁完全坏死。切除了直肠组织的坏死部分,并对盆腔内的坏死组织进行了引流和灌洗。剩余的直肠通过部分乙状结肠切除术进行了切除,但我们无法使肛门残端闭合。此外,还进行了乙状结肠末端结肠造口术。组织病理结果显示,直肠系膜静脉内有血栓形成。第一次手术后,盆腔脓腔持续存在,高烧不退。再次手术在腹腔镜下进行,她接受了肛管切除术,切除了残留的坏死直肠和直肠系膜组织,并引流了盆腔脓肿。再次手术后,她的全身情况有所好转,CT显示脓腔已明显改善:结论:胃肠道穿孔,尤其是由严重 COVID19 感染引起的凝血功能障碍导致的直肠坏死,是一种罕见但危及生命的并发症。医生在临床上应高度怀疑,以便及时诊断和处理,对于直肠坏死病例必须进行手术干预。
{"title":"Rectum necrosis in a patient with severe COVID19 infection after CAR-T therapy: a case report.","authors":"Kiyoshi Saeki, Hidenobu Nakagama, Yuichi Tanaka, Yoshitaka Goto, Kazuhisa Kaneshiro, Hiroshi Kono, Kosuke Yanai, Hirofumi Yamamoto, Reiko Yoneda, Takashi Shimakawa, Takashi Ueki","doi":"10.1186/s40792-024-02026-1","DOIUrl":"https://doi.org/10.1186/s40792-024-02026-1","url":null,"abstract":"<p><strong>Background: </strong>Coronavirus disease 2019 (COVID19) can cause gastrointestinal complications as well as respiratory tract disease. Coagulation abnormalities and thrombosis frequently occur in COVID19, especially in cases with severe clinical outcome. The relationship between gastrointestinal perforation and coagulopathy due to COVID19 remains unclear.</p><p><strong>Case presentation: </strong>A 49-year-old female received Chimeric antigen receptor T (CAR-T) therapy for an early recurrence of diffuse large B-cell lymphoma (DLBCL) that was refractory to chemotherapy. She was diagnosed with cytokine release syndrome (CRS) because of a fever and oxygen desaturation, and administered tocilizumab. Forty days after completing CAR-T therapy, she was infected with COVID19 and transferred to our hospital. Her general condition worsened and she developed COVID19 pneumonia, and then steroid pulse therapy was started. While her respiratory condition improved, she experienced pain in the anal region and computed tomography (CT) revealed a rectal perforation. An emergency surgery was undertaken, and the lower rectum wall was found to be completely necrotic. Removal of the necrotic part of the rectum tissue, and drainage and lavage of necrotic tissue in the pelvic cavity were performed. The remaining rectum was resected with partial sigmoidectomy, but we could not make the anal stump closed. In addition, an end colostomy in the sigmoid colon was performed. Histopathological findings showed thromboses in the rectal mesentery veins. After the first surgery, the pelvic abscess cavity persisted and her high-grade fever continued. Reoperation was laparoscopically performed, and she underwent a resection of anal canal with residual necrotic rectal and mesorectal tissue, and a drainage of the pelvic abscess. After the reoperation, her general condition improved and CT showed that the abscess cavity had significantly improved.</p><p><strong>Conclusions: </strong>Gastrointestinal perforation, especially rectal necrosis due to coagulopathy caused by severe COVID19 infection, is a rare but life-threatening complication. Physicians should have a high degree of clinical suspicion for timely diagnosis and management, and surgical intervention is necessary in cases of rectal necrosis.</p>","PeriodicalId":22096,"journal":{"name":"Surgical Case Reports","volume":"10 1","pages":"227"},"PeriodicalIF":0.7,"publicationDate":"2024-09-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11427651/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142354235","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
An extremely rare case of thymic squamous cell carcinoma complicated with B3 thymoma and myasthenia gravis: a case report. 一例极为罕见的胸腺鳞状细胞癌并发 B3 胸腺瘤和重症肌无力:病例报告。
IF 0.7 Q4 SURGERY Pub Date : 2024-09-26 DOI: 10.1186/s40792-024-02025-2
Maiko Atari, Hideki Kawai, Takuo Tokairin

Background: Thymomas complicated with myasthenia gravis are conventionally treated during thoracic surgery. Particularly, invasive thymomas are resected alongside the surrounding organs. Here, we present a case where surgical and perioperative management was performed under the presumption of thymoma with myasthenia gravis. However, definitive pathology revealed the co-occurrence of B3 thymoma and thymic squamous cell carcinoma. This case highlights the unique presentation and exceptional rarity of thymomas that are complicated by myasthenia gravis and thymic carcinoma.

Case presentation: A 65-year-old female presented with eyelid ptosis at our hospital. Following a comprehensive examination, the patient was diagnosed with myasthenia gravis. Her computed tomography (CT) scan revealed an anterior mediastinal tumor suggestive of a thymoma, prompting a referral to the Department of Thoracic Surgery. Moreover, preoperative assessment could not definitively exclude pericardial invasion. She subsequently underwent an extended thymectomy via a longitudinal sternal incision. The tumor exhibited partial invasion of the pericardium, necessitating resection and reconstruction. Definitive pathological examination confirmed the co-occurrence of B3 thymoma and thymic squamous cell carcinoma. Positive lymph node metastasis classified the patient as stage IVa according to the Union for International Cancer Control (UICC) TNM Classification of Malignant Tumors, 8th Edition, and she was started on adjuvant radiotherapy postoperatively. Currently, the patient remains under observation, with follow-up CT scans showing no signs of recurrence.

Conclusions: This report describes an extremely rare case of thymoma complicated with myasthenia gravis and thymic squamous cell carcinoma.

背景:胸腺瘤并发重症肌无力通常在胸腔手术中进行治疗。特别是,侵袭性胸腺瘤与周围器官一起被切除。在这里,我们介绍了一个病例,该病例的手术和围手术期处理是在推测胸腺瘤合并重症肌无力的情况下进行的。然而,最终的病理结果显示,B3 胸腺瘤和胸腺鳞状细胞癌同时存在。本病例突显了胸腺瘤并发重症肌无力和胸腺癌的独特表现和罕见性:一名 65 岁的女性因眼睑下垂来我院就诊。经过全面检查,患者被诊断为重症肌无力。她的计算机断层扫描(CT)发现前纵隔肿瘤,提示为胸腺瘤,遂转诊至胸外科。此外,术前评估无法明确排除心包侵犯。随后,她通过胸骨纵切口接受了胸腺扩大切除术。肿瘤部分侵犯了心包,需要进行切除和重建。最终病理检查证实,患者同时患有 B3 胸腺瘤和胸腺鳞状细胞癌。根据国际癌症控制联盟(UICC)《恶性肿瘤 TNM 分类》(第 8 版),淋巴结转移阳性将患者归为 IVa 期,术后她开始接受辅助放疗。目前,患者仍在接受观察,后续的 CT 扫描显示没有复发迹象:本报告描述了一例极为罕见的胸腺瘤并发重症肌无力和胸腺鳞状细胞癌的病例。
{"title":"An extremely rare case of thymic squamous cell carcinoma complicated with B3 thymoma and myasthenia gravis: a case report.","authors":"Maiko Atari, Hideki Kawai, Takuo Tokairin","doi":"10.1186/s40792-024-02025-2","DOIUrl":"https://doi.org/10.1186/s40792-024-02025-2","url":null,"abstract":"<p><strong>Background: </strong>Thymomas complicated with myasthenia gravis are conventionally treated during thoracic surgery. Particularly, invasive thymomas are resected alongside the surrounding organs. Here, we present a case where surgical and perioperative management was performed under the presumption of thymoma with myasthenia gravis. However, definitive pathology revealed the co-occurrence of B3 thymoma and thymic squamous cell carcinoma. This case highlights the unique presentation and exceptional rarity of thymomas that are complicated by myasthenia gravis and thymic carcinoma.</p><p><strong>Case presentation: </strong>A 65-year-old female presented with eyelid ptosis at our hospital. Following a comprehensive examination, the patient was diagnosed with myasthenia gravis. Her computed tomography (CT) scan revealed an anterior mediastinal tumor suggestive of a thymoma, prompting a referral to the Department of Thoracic Surgery. Moreover, preoperative assessment could not definitively exclude pericardial invasion. She subsequently underwent an extended thymectomy via a longitudinal sternal incision. The tumor exhibited partial invasion of the pericardium, necessitating resection and reconstruction. Definitive pathological examination confirmed the co-occurrence of B3 thymoma and thymic squamous cell carcinoma. Positive lymph node metastasis classified the patient as stage IVa according to the Union for International Cancer Control (UICC) TNM Classification of Malignant Tumors, 8th Edition, and she was started on adjuvant radiotherapy postoperatively. Currently, the patient remains under observation, with follow-up CT scans showing no signs of recurrence.</p><p><strong>Conclusions: </strong>This report describes an extremely rare case of thymoma complicated with myasthenia gravis and thymic squamous cell carcinoma.</p>","PeriodicalId":22096,"journal":{"name":"Surgical Case Reports","volume":"10 1","pages":"224"},"PeriodicalIF":0.7,"publicationDate":"2024-09-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11427628/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142354233","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Stage IV gastric cancer with microsatellite instability–high achieving long-term survival by gastrectomy after nivolumab as third-line therapy: a case report and literature review 微卫星不稳定的IV期胃癌--尼妥珠单抗作为三线疗法后通过胃切除术获得长期生存:病例报告和文献综述
IF 0.8 Q4 SURGERY Pub Date : 2024-09-19 DOI: 10.1186/s40792-024-02022-5
Hideki Kumagai, Shigeaki Baba, Haruka Nikai, Ryosuke Fujisawa, Misato Shimooki, Akira Sasaki
The prognosis for stage IV gastric cancer remains poor; however, the advent of immune checkpoint inhibitors (ICIs) such as nivolumab has increased the number of patients with long-term survival. Patients with microsatellite instability (MSI)–high gastric cancer have been recognized as a highly effective population for ICIs. Herein, we report a patient with MSI–high advanced gastric cancer treated with gastrectomy after the administration of nivolumab as third-line therapy. A 73-year-old woman presented with a type 3 tumor in the lower part of the gastric body, which was diagnosed as gastric cancer through biopsy. Staging laparoscopy revealed that the tumor had invaded the pancreas and the posterior lobe of the transverse mesocolon, and disseminated nodules were found near the ligament of Treitz. After 4 courses of S-1 plus cisplatin therapy, laparoscopic gastrojejunal bypass was performed because of difficulty in oral intake. She received S-1 plus oxaliplatin therapy after a gastrojejunal bypass; however, her regional lymph nodes were enlarged. After six courses of paclitaxel plus ramucirumab as second-line chemotherapy, computed tomography (CT) showed exacerbation of peritoneal dissemination; thus, nivolumab was selected as the third-line therapy. The tumor was characterized by MSI–high. At 24 courses, CT and gastroscopy revealed a complete clinical response of the tumor; however, re-growth of the primary tumor was observed at 36 courses. The patient underwent distal gastrectomy with D1 + lymph node dissection, and received S-1 monotherapy as adjuvant therapy for 1 year. No recurrence was noted at 39 months after the surgery. We report a patient with highly advanced gastric cancer with peritoneal dissemination, which worsened during second-line therapy and was successfully treated with gastrectomy after nivolumab administration as a third-line therapy. MSI–high gastric cancer is a target that should be actively considered for the administration of ICIs, such as nivolumab, and multidisciplinary treatment combined with chemotherapy and gastrectomy, including conversion surgery, can lead to patients’ long-term survival.
IV 期胃癌的预后仍然很差;然而,免疫检查点抑制剂(ICIs)(如 nivolumab)的出现增加了长期生存患者的数量。微卫星不稳定性(MSI)高的胃癌患者被认为是 ICIs 的高效人群。在此,我们报告了一名微卫星不稳定性(MSI)高的晚期胃癌患者在接受 nivolumab 三线治疗后接受胃切除术的情况。一名 73 岁的女性患者因胃体下部 3 型肿瘤就诊,经活检确诊为胃癌。分期腹腔镜检查显示,肿瘤已侵犯胰腺和结肠横系膜后叶,并在特雷兹韧带附近发现播散性结节。在接受了4个疗程的S-1加顺铂治疗后,由于口服困难,她接受了腹腔镜胃空肠分流术。胃空肠旁路术后,她又接受了 S-1 加奥沙利铂治疗,但区域淋巴结肿大。紫杉醇加雷莫芦单抗二线化疗六个疗程后,计算机断层扫描(CT)显示腹膜播散加重,因此选择尼伐单抗作为三线疗法。肿瘤特征为 MSI-高。24 个疗程后,CT 和胃镜检查显示肿瘤出现了完全临床反应;但在 36 个疗程时,观察到原发肿瘤再次生长。患者接受了远端胃切除术和 D1 + 淋巴结清扫术,并接受 S-1 单药辅助治疗 1 年。术后 39 个月未见复发。我们报告了一名伴有腹膜播散的高分化胃癌患者,该患者在二线治疗期间病情恶化,在接受尼妥珠单抗作为三线治疗后,成功接受了胃切除术。MSI高的胃癌是应积极考虑使用尼妥珠单抗等ICIs的靶点,化疗和胃切除术(包括转换手术)等多学科联合治疗可使患者获得长期生存。
{"title":"Stage IV gastric cancer with microsatellite instability–high achieving long-term survival by gastrectomy after nivolumab as third-line therapy: a case report and literature review","authors":"Hideki Kumagai, Shigeaki Baba, Haruka Nikai, Ryosuke Fujisawa, Misato Shimooki, Akira Sasaki","doi":"10.1186/s40792-024-02022-5","DOIUrl":"https://doi.org/10.1186/s40792-024-02022-5","url":null,"abstract":"The prognosis for stage IV gastric cancer remains poor; however, the advent of immune checkpoint inhibitors (ICIs) such as nivolumab has increased the number of patients with long-term survival. Patients with microsatellite instability (MSI)–high gastric cancer have been recognized as a highly effective population for ICIs. Herein, we report a patient with MSI–high advanced gastric cancer treated with gastrectomy after the administration of nivolumab as third-line therapy. A 73-year-old woman presented with a type 3 tumor in the lower part of the gastric body, which was diagnosed as gastric cancer through biopsy. Staging laparoscopy revealed that the tumor had invaded the pancreas and the posterior lobe of the transverse mesocolon, and disseminated nodules were found near the ligament of Treitz. After 4 courses of S-1 plus cisplatin therapy, laparoscopic gastrojejunal bypass was performed because of difficulty in oral intake. She received S-1 plus oxaliplatin therapy after a gastrojejunal bypass; however, her regional lymph nodes were enlarged. After six courses of paclitaxel plus ramucirumab as second-line chemotherapy, computed tomography (CT) showed exacerbation of peritoneal dissemination; thus, nivolumab was selected as the third-line therapy. The tumor was characterized by MSI–high. At 24 courses, CT and gastroscopy revealed a complete clinical response of the tumor; however, re-growth of the primary tumor was observed at 36 courses. The patient underwent distal gastrectomy with D1 + lymph node dissection, and received S-1 monotherapy as adjuvant therapy for 1 year. No recurrence was noted at 39 months after the surgery. We report a patient with highly advanced gastric cancer with peritoneal dissemination, which worsened during second-line therapy and was successfully treated with gastrectomy after nivolumab administration as a third-line therapy. MSI–high gastric cancer is a target that should be actively considered for the administration of ICIs, such as nivolumab, and multidisciplinary treatment combined with chemotherapy and gastrectomy, including conversion surgery, can lead to patients’ long-term survival.","PeriodicalId":22096,"journal":{"name":"Surgical Case Reports","volume":"64 1","pages":""},"PeriodicalIF":0.8,"publicationDate":"2024-09-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142265150","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Successful outcome achieved with adjuvant chemotherapy with irinotecan plus cisplatin in rectal neuroendocrine carcinoma: a case report 直肠神经内分泌癌辅助化疗伊立替康加顺铂取得成功:病例报告
IF 0.8 Q4 SURGERY Pub Date : 2024-09-19 DOI: 10.1186/s40792-024-02010-9
Yoshitaka Saegusa, Shintaro Akabane, Manabu Shimomura, Hiroshi Okuda, Takuya Yano, Tetsuya Mochizuki, Wako Inoue, Mizuki Yamaguchi, Shinji Yamaguchi, Kazuhiro Sentani, Masami Yamauchi, Kentaro Tokumo, Hideki Ohdan
Rectal neuroendocrine carcinomas (NECs) are rare and associated with poorer prognoses compared to conventional adenocarcinomas. The efficacy of adjuvant chemotherapy for resectable rectal NECs remains uncertain. Herein, we present a case of rectal NEC successfully treated with postoperative chemotherapy using irinotecan plus cisplatin. A 48-year-old woman with a history of endometrial cancer presented with an intramural rectal tumour detected on follow-up imaging. Colonoscopy revealed a 30 mm submucosal tumour, and laparoscopic low anterior resection was performed. Histopathological examination showed poorly differentiated atypical cells with solid growth patterns. Metastasis from the uterine cancer was ruled out due to histological differences between the primary uterine tumour and the rectal lesion, as well as the absence of hormone receptor immunohistochemical expression. Further immunohistochemical analysis revealed diffuse CD56 positivity, a high mitotic rate (> 20/10 high power fields) and a Ki-67 labelling index exceeding 70%. Based on these findings, a diagnosis of rectal NEC, T3N0M0, Stage IIB (UICC 8th edition), was established. Given the aggressive nature of the tumour evidenced by a high Ki-67 labelling index, adjuvant chemotherapy comprising six cycles of irinotecan plus cisplatin was administered to mitigate the risk of recurrence. At the 3-year follow-up, the patient was free of disease recurrence. This case highlights the importance of multidisciplinary surgical interventions followed by adjuvant chemotherapy in managing rectal NECs.
直肠神经内分泌癌(NEC)十分罕见,与传统腺癌相比,其预后较差。对于可切除的直肠NEC,辅助化疗的疗效仍不确定。在此,我们介绍一例使用伊立替康加顺铂术后化疗成功治疗直肠NEC的病例。一位 48 岁的女性患者曾患子宫内膜癌,随访造影时发现直肠内肿瘤。结肠镜检查发现了一个 30 毫米的黏膜下肿瘤,于是进行了腹腔镜低位前切除术。组织病理学检查显示,肿瘤为分化不良的非典型细胞,呈实性生长。由于原发子宫肿瘤和直肠病变在组织学上存在差异,而且没有激素受体免疫组化表达,因此排除了子宫癌转移的可能性。进一步的免疫组化分析显示,CD56呈弥漫阳性,有丝分裂率高(> 20/10 高倍视野),Ki-67标记指数超过70%。根据这些结果,确诊为直肠 NEC,T3N0M0,IIB 期(UICC 第 8 版)。鉴于肿瘤的侵袭性(Ki-67标记指数较高),患者接受了伊立替康加顺铂的辅助化疗,共6个周期,以降低复发风险。在 3 年的随访中,患者没有再复发。本病例强调了多学科手术干预和辅助化疗在治疗直肠坏死性溃疡中的重要性。
{"title":"Successful outcome achieved with adjuvant chemotherapy with irinotecan plus cisplatin in rectal neuroendocrine carcinoma: a case report","authors":"Yoshitaka Saegusa, Shintaro Akabane, Manabu Shimomura, Hiroshi Okuda, Takuya Yano, Tetsuya Mochizuki, Wako Inoue, Mizuki Yamaguchi, Shinji Yamaguchi, Kazuhiro Sentani, Masami Yamauchi, Kentaro Tokumo, Hideki Ohdan","doi":"10.1186/s40792-024-02010-9","DOIUrl":"https://doi.org/10.1186/s40792-024-02010-9","url":null,"abstract":"Rectal neuroendocrine carcinomas (NECs) are rare and associated with poorer prognoses compared to conventional adenocarcinomas. The efficacy of adjuvant chemotherapy for resectable rectal NECs remains uncertain. Herein, we present a case of rectal NEC successfully treated with postoperative chemotherapy using irinotecan plus cisplatin. A 48-year-old woman with a history of endometrial cancer presented with an intramural rectal tumour detected on follow-up imaging. Colonoscopy revealed a 30 mm submucosal tumour, and laparoscopic low anterior resection was performed. Histopathological examination showed poorly differentiated atypical cells with solid growth patterns. Metastasis from the uterine cancer was ruled out due to histological differences between the primary uterine tumour and the rectal lesion, as well as the absence of hormone receptor immunohistochemical expression. Further immunohistochemical analysis revealed diffuse CD56 positivity, a high mitotic rate (> 20/10 high power fields) and a Ki-67 labelling index exceeding 70%. Based on these findings, a diagnosis of rectal NEC, T3N0M0, Stage IIB (UICC 8th edition), was established. Given the aggressive nature of the tumour evidenced by a high Ki-67 labelling index, adjuvant chemotherapy comprising six cycles of irinotecan plus cisplatin was administered to mitigate the risk of recurrence. At the 3-year follow-up, the patient was free of disease recurrence. This case highlights the importance of multidisciplinary surgical interventions followed by adjuvant chemotherapy in managing rectal NECs.","PeriodicalId":22096,"journal":{"name":"Surgical Case Reports","volume":"19 1","pages":""},"PeriodicalIF":0.8,"publicationDate":"2024-09-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142265151","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Surgical Case Reports
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1